DIN 02537214 — BEYFORTUS 100 MG
BEYFORTUS is a solution of Nirsevimab marketed by SANOFI VACCINES CANADA LTD.. The full Nirsevimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02537214
- Brand name
- BEYFORTUS
- Active ingredient
- Nirsevimab
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- SANOFI VACCINES CANADA LTD.
- Health Canada status
- MARKETED
- Drug class
- Passive immunizing agent (human monoclonal antibody, RSV fusion protein inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nirsevimab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02537206 | BEYFORTUS | 50 MG | SOLUTION | SANOFI VACCINES CANADA LTD. | MARKETED |